The effects of cyclin overproduction on proliferation and genome stability are difficult to dissect in fully developed cancer cells because the cyclin changes are combined with many genetic and epigenetic changes that activate growth signaling, inhibit apoptosis, and impair checkpoints (Hanahan & Weinberg, 2011). The gene discussed is PCNA; the disease is cancer.